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Letters to the Editoranticoagulation with mechanical
valve replacement, should be balanced
against the risk of proximal reopera-
tion during follow-up. Regarding
the published experiences of centers
favoring aortic root preservation in
the setting of acute type A dissection,
it has been our institution’s policy to
consider more definitive aortic root
repair for patients presenting with
dissection of all sinuses, an aortic
root diameter>47 mm, or dissection
extending to the iliac arteries.2-4
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To the Editor:
Currently, invasive mechanical
ventilation (IMV) in patients with
fibrosing interstitial pneumonia is a
devastating situation in the intensive
care unit (ICU). After 2 decades, the
prognosis is still poor.
Gaudry and colleagues,1 in an orig-
inal retrospective multicenter French
study, describe short- and long-termThe Journaloutcomes in critically patients with
fibrotic lung diseases undergoing
IMV. In their view, more frequent use
of lung protective strategies may influ-
ence poor outcomes, and individual
evaluation case-by-case evaluation is
needed for appropriate discrimination
of ICU patients. Their arguments are
solid, rational, and comprehensive
for current practice and across all
published studies, although major
drawbacks of this study were its retro-
spective design and limited number of
patients, Obviously, the recommenda-
tions are reasonable and appropriate;
however, some points need to be taken
into account:
First, the authors did not describe
reasons for underuse of lower-level
aggressive ventilation alternatives
before IMV in these populations.
Were the use of noninvasive ventila-
tion and criteria for IMV in this study
reflected properly? Recently, new
and promising observations have
emerged: (1) Although there is still
only a small number of studies, early
use of noninvasive ventilation in
selected patients may avoid IMV and
improve clinical conditions at ICU
admission.2 (2) Nasal high-flow cannu-
lation may improve oxygenation in
concert with low positive end-
expiratorypressure in selectedpatients.
Some patients with pulmonary fibrosis
have been treated under expanded indi-
cations for nasal high-flow cannulation
with promising results.3
Second, it is interesting that patients
who met criteria for lung transplant
and were breathing spontaneously
with noninvasive ventilation have
shown the best outcome as bridge to
lung transplant and adequate results
after bilateral lung transplant.4 These
are promising alternatives to IMV for
selected patients.2-4
Third, lung-protective ventilation
arguably provides the best hope for
good results of IMV in these patients.
It is a reasonable hope; however, lung
damage is currently equally associ-
ated with high levels of inspiratory
oxygenation fraction and low tidalof Thoracic and Cardiovascular Surgervolume with high or normal positive
end-expiratory pressure.5 Although
large, prospective studies are nonexis-
tent, it is a promising avenue.
Finally, it would be interesting to
know details regarding survivors that
are lacking in these studies, such as
measurements of health-related qual-
ity of life, and the influence of specific
natural history, such as rates of hospi-
tal admission and exacerbations after
ICU discharge and impact of early
pulmonary rehabilitative programs.
Further large international database
studies will illuminate solid bases to
define risk factors and prognosis in
these directions.
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We thank Dr Esquinas for his com-
ments and interest in our work.1 First,
we would like to underline that our
goal was not to promote invasive me-
chanical ventilation (IMV) for patients
with end-stage fibrosing interstitial
pneumonia but rather to provide an
update on their prognosis. Obviously,y c Volume 147, Number 3 1113
Letters to the Editorseveral options must be discussed, and
our contention is that IMV should not
be systematically denied in case of
acute respiratory failure (ARF).
As indicated in our article,1 a large
proportion of our patients (19/27;
70%) underwent noninvasive ventila-
tion (NIV) before intubation. Even if
NIVis sometimes an interesting option
in the management of acute exacerba-
tion of chronic interstitial pneumonia,2
its effectiveness remains questionable
for that as well as hypoxemic ARF.3
In a retrospective study cited by
Esquinas, G€ung€or and colleagues4
concluded that NIV could be an option
in less severely ill patients with Acute
Physiology And Chronic Health Eval-
uation II scores less than 20. In com-
parison, our patients had an average
Acute Physiology And Chronic Health
Evaluation score II of 22  11. Other-
wise, high-flow nasal cannula oxygen
(HFNC) is a very attractive option for
the treatment of hypoxemic ARF.
Observational studies suggest that
HFNC might reduce the need for
intubation in this setting by improving
oxygenation.5,6 Our patients did
not receive HFNC, because this
technique was not used in the
participating intensive care units at
the time of the study (2002-2009).
Today, we routinely use HFNC in
patients with ARF complicating
fibrotic interstitial pneumonia.
As discussed in our article, recent
studies evaluating extracorporeal mem-
brane oxygenation as a bridge to lung
transplant have yielded very encour-
aging results.7,8 This strategymay prove
beneficial for these patients because it
improves oxygenation, allows patients
to be kept awake and sometimes
spontaneously breathing, and enables
pretransplant rehabilitation.9 In light of
the recent article by Crotti and col-
leagues,10 we think, unlike Dr Esquinas,
that it is not possible to conclude that
NIV combined with extracorporeal
membrane oxygenation allows better
outcome as a bridge to lung transplant.
Indeed, in this retrospective study,10
patients receiving IMV (n ¼ 9)1114 The Journal of Thoracic andprobably had more severe conditions
than patients receiving NIV (n ¼ 8) as
attested by their Sequential Organ Fail-
ure Assessment score before lung
transplant (8.7  1.9 vs 6.5  2.6,
respectively; P ¼ .07). Moreover the
1-year survivals in the 2 groups were
similar (75% vs 77%).
Lung-protective ventilation is
certainly a major breakthrough of
recent years, and this ventilation strat-
egy is particularly appropriate for pa-
tients with very low lung compliance,
as in the cases of acute respiratory
distress syndrome (ARDS) and pulmo-
nary fibrosis. In acute respiratory
distress syndrome, the optimal level
positive end-expiratory pressure
remains open to debate.11 A few data
suggest that high positive end-
expiratorypressure levels are associated
with decreased survival in patients with
interstitial lung disease on IMV.12
Finally, we did not evaluate the
health-related quality of life after
intensive care unit discharge. We
think that satisfactory health-related
quality of life cannot be achieved
for these patients in the absence of
lung transplant, which is the only
long-lasting way to improve survival
and health-related quality of life.
Stephane Gaudry, MDa
Yves Cohen, MD, PhDb
Antoine Rabbat, MDc
Herve Mal, MD, PhDd
aService de Reanimation Medicale et
des Maladies Infectieuses
Ho^pital Bichat
Assistance Publique Ho^pitaux de
Paris
Universite Denis Diderot
Paris, France
bService de Reanimation Medico-
Chirurgicale
Ho^pital Avicenne
Assistance Publique Ho^pitaux de
Paris
Bobigny, France
cService de Reanimation Respiratoire
Ho^tel Dieu
Assistance Publique Ho^pitaux de
ParisCardiovascular Surgery c March 2014Paris, France
dService de Pneumologie B
Ho^pital Bichat
Assistance Publique Ho^pitaux de
Paris
Universite Denis Diderot
Paris, France
References
1. Gaudry S, Vincent F, Rabbat A, Nunes H,
Crestani B, Naccache JM, et al. Invasive mechan-
ical ventilation in patients with fibrosing intersti-
tial pneumonia. J Thorac Cardiovasc Surg.
2014;147:47-53.
2. Tomii K, Tachikawa R, Chin K, Murase K,
Handa T, Mishima M, et al. Role of non-
invasive ventilation in managing life-threatening
acute exacerbation of interstitial pneumonia.
Intern Med. 2010;49:1341-7.
3. Nava S, Schreiber A, Domenighetti G. Noninva-
sive ventilation for patients with acute lung injury
or acute respiratory distress syndrome. Respir
Care. 2011;56:1583-8.
4. G€ung€orG, TatarD, Salt€urkC, C¸imen P,Karakurt Z,
Kirakli C, et al. Why do patients with interstitial
lung diseases fail in the ICU? A 2-center cohort
study. Respir Care. 2013;58:525-31.
5. Ricard JD. High flow nasal oxygen in acute
respiratory failure. Minerva Anestesiol. 2012;78:
836-41.
6. Sztrymf B, Messika J, Bertrand F, Hurel D,
Leon R, Dreyfuss D, et al. Beneficial effects of
humidified high flow nasal oxygen in critical
care patients: a prospective pilot study. Intensive
Care Med. 2011;37:1780-6.
7. Hoopes CW, Kukreja J, Golden J, Davenport DL,
Diaz-Guzman E, Zwischenberger JB. Extracorpo-
real membrane oxygenation as a bridge to pulmo-
nary transplantation. J Thorac Cardiovasc Surg.
2013;145:862-7; discussion 867-8.
8. Toyoda Y, Bhama JK, Shigemura N, Zaldonis D,
Pilewski J, Crespo M, et al. Efficacy of extracor-
poreal membrane oxygenation as a bridge to
lung transplantation. J Thorac Cardiovasc Surg.
2013;145:1065-70; discussion 1070-1.
9. Fuehner T, Kuehn C, Hadem J, Wiesner O,
Gottlieb J, Tudorache I, et al. Extracorporeal
membrane oxygenation in awake patients as
bridge to lung transplantation. Am J Respir Crit
Care Med. 2012;185:763-8.
10. Crotti S, Iotti GA, Lissoni A, Belliato M,
Zanierato M, Chierichetti M, et al. Organ alloca-
tion waiting time during extracorporeal bridge to
lung transplant affects outcomes. Chest. 2013;
144:1018-25.
11. Briel M, Meade M, Mercat A, Brower RG,
Talmor D, Walter SD, et al. Higher vs lower pos-
itive end-expiratory pressure in patients with acute
lung injury and acute respiratory distress syn-
drome: systematic review and meta-analysis.
JAMA. 2010;303:865-73.
12. Fernandez-Perez ER, Yilmaz M, Jenad H,
Daniels CE, Ryu JH, Hubmayr RD, et al. Venti-
lator settings and outcome of respiratory failure
in chronic interstitial lung disease. Chest. 2008;
133:1113-9.
http://dx.doi.org/10.1016/
j.jtcvs.2013.11.008
